| Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy S Prasad, RK Dhiman, A Duseja, YK Chawla, A Sharma, R Agarwal Hepatology 45 (3), 549-559, 2007 | 721 | 2007 |
| Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update SK Sarin, A Choudhury, MK Sharma, R Maiwall, M Al Mahtab, S Rahman, ... Hepatology international 13, 353-390, 2019 | 704 | 2019 |
| Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ... Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019 | 682 | 2019 |
| Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—part 1: definition, risk factors and assessment VWS Wong, WK Chan, S Chitturi, Y Chawla, YY Dan, A Duseja, J Fan, ... Journal of gastroenterology and hepatology 33 (1), 70-85, 2018 | 494 | 2018 |
| Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial RK Dhiman, B Rana, S Agrawal, A Garg, M Chopra, KK Thumburu, ... Gastroenterology 147 (6), 1327-1337. e3, 2014 | 367 | 2014 |
| Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy A Gupta, RK Dhiman, S Kumari, S Rana, R Agarwal, A Duseja, Y Chawla Journal of hepatology 53 (5), 849-855, 2010 | 251 | 2010 |
| Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver RK Dhiman, R Kurmi, KK Thumburu, SH Venkataramarao, R Agarwal, ... Digestive diseases and sciences 55, 2381-2390, 2010 | 238 | 2010 |
| The modern management of portal vein thrombosis Y Chawla, A Duseja, RK Dhiman Alimentary pharmacology & therapeutics 30 (9), 881-894, 2009 | 228 | 2009 |
| The Asia–Pacific Working Party on non‐alcoholic fatty liver disease guidelines 2017—part 2: management and special groups S Chitturi, VWS Wong, WK Chan, GLH Wong, SKH Wong, J Sollano, ... Journal of gastroenterology and hepatology 33 (1), 86-98, 2018 | 196 | 2018 |
| Small intestinal bacterial overgrowth and toll‐like receptor signaling in patients with non‐alcoholic fatty liver disease S Kapil, A Duseja, BK Sharma, B Singla, A Chakraborti, A Das, P Ray, ... Journal of gastroenterology and hepatology 31 (1), 213-221, 2016 | 193 | 2016 |
| Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver RK Dhiman, VA Saraswat, BK Sharma, SK Sarin, YK Chawla, ... Journal of Gastroenterology and Hepatology 25 (6), 1029-1041, 2010 | 191 | 2010 |
| Non-alcoholic fatty liver disease and metabolic syndrome—position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian … A Duseja, SP Singh, VA Saraswat, SK Acharya, YK Chawla, S Chowdhury, ... Journal of clinical and experimental hepatology 5 (1), 51-68, 2015 | 188 | 2015 |
| Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End‐Stage Liver Disease (MELD) and King's College Hospital criteria RK Dhiman, S Jain, U Maheshwari, A Bhalla, N Sharma, J Ahluwalia, ... Liver transplantation 13 (6), 814-821, 2007 | 181 | 2007 |
| The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ... Journal of hepatology 76 (4), 771-780, 2022 | 175 | 2022 |
| Nonalcoholic fatty liver disease in India–a lot done, yet more required! A Duseja Indian Journal of Gastroenterology 29, 217-225, 2010 | 159 | 2010 |
| The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West A Duseja, A Das, R Das, RK Dhiman, Y Chawla, A Bhansali, N Kalra Digestive diseases and sciences 52, 2368-2374, 2007 | 148 | 2007 |
| Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions A Duseja, A Das, RK Dhiman, YK Chawla, KK Thumburu, S Bhadada, ... Annals of Hepatology 6 (4), 222-226, 2007 | 144 | 2007 |
| Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease ZM Younossi, M Stepanova, J Ong, Y Yilmaz, A Duseja, Y Eguchi, ... Clinical Gastroenterology and Hepatology 17 (8), 1625-1633. e1, 2019 | 140 | 2019 |
| Obesity and NAFLD: the role of bacteria and microbiota A Duseja, YK Chawla Clinics in liver disease 18 (1), 59-71, 2014 | 132 | 2014 |
| High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study A Duseja, SK Acharya, M Mehta, S Chhabra, S Rana, A Das, ... BMJ open gastroenterology 6 (1), e000315, 2019 | 127 | 2019 |
